sciRNA characterization and expression sciRNAs were aligned to genome mm10 or hg19 using Bowtie 0.12.7 (6) with parameters -v 1 -a --best --strata. Because many sciRNAs may align to thousands of genomic locations, a stepwise prioritization process was used to annotate them (listed in descending priority): [1] the sciRNA was found to be Dicer-dependent and Dgcr8-independent (2), [2] the sciRNA overlaps a miRBase (7) miRNA or Rfam (8) pre-miRNA +/-3nt, [3] the sciRNA overlaps a non-miRNA Rfam annotation +/-3nt, [4] the sciRNA is a sub-sequence of a piRNABank (9) annotated piRNA, [5] the sciRNA overlaps a region from our custom merged annotation described earlier, [6] no annotation, [7] unmapped. If a category had 3 or fewer members, it was labeled as "other" in Figure 3a .
We next predicted whether a sciRNA was derived from a long hairpin RNA (hpRNA) structure. For each sciRNA, we applied RNAfold (10) to the region flanking its genomic alignment (+/-500nt). If the sciRNA was aligned to multiple genomic locations, the region (+/-500nt) with the highest read coverage was used. Then, RNAfold's dot bracket notation was used to examine whether the sciRNA aligned to the stem of a long secondary structure, i.e. "long hpRNA." Namely, two criteria were used: stem length ≥70, and ≥70% of the sciRNA nucleotides (length 19-24) were structured (brackets). Stem length was calculated as the distance to the next opposite-facing bracket (equal to zero if the sciRNA contained two opposite facing brackets). These thresholds were chosen by checking that previously identified endo-siRNAs (e.g. miR-1195 and miR-1965) in mESCs were included and manually checking the RNAfold structure prediction for some novel examples (e.g. Ccdc30 shown in Figure 3b ). In addition, several thresholds were tested, and although stem length ≥70 and ≥70% structured were the optimal thresholds, the results were largely robust to choice of stem length and percent nucleotides structured.
Small RNA expression was calculated using reads per million (RPM), where sequencing depth for each sample only included small RNAs that passed the preprocessing steps in the pipeline (i.e. masked small repeats and length [19, 24] ). sciRNAs identified in mESCs and/or testis 6M PN were clustered across all testis developmental stages, and similarly for mESCs and/or cerebellum 6M PN. sciRNAs with RPM ≥ 1 were grouped based on whether they targeted a transcript in mESCs, adult tissue, or both. miRNAs with minimum read count 20 in at least one sample were clustered since this minimum read count was used in the preprocessing pipeline to identify sciRNAs. miRNAs with RPM ≥ 1 were labeled as adult tissue, mESCs, or both based on read count ≥ 20 in these samples. R function heatmap.2 was used for hierarchical clustering with Euclidean distance and complete linkage.
Target characterization
Cleavage sites (Deg-Seq peaks) were characterized by genic location and by type of transcript. If the Deg-Seq peak overlapped multiple transcripts, the genic regions were prioritized as follows:
coding exon (CDS exon) > 5'UTR exon > 3'UTR exon > exon in non-coding transcripts (NC exon) > intron in coding genes > 5'UTR intron > 3'UTR intron > intron in non-coding transcripts. Transcripts harboring the cleavage sites were also examined for their types: coding, pseudogene, lncRNA, or other non-coding RNAs. Finally, Repeatmasker was used to decide whether a cleavage site overlaps a repetitive sequence. To test if the observed gene region and Repeatmasker enrichment at cleavage sites significantly differed from the transcriptome overall, 100 random positions per Deg-Seq peak were chosen from any annotated transcript. If a random position overlapped multiple transcripts, the genic regions were prioritized using the above prioritization schemes (Figure 4b, 5b ).
Functional analysis of target genes
Gene set enrichment. Ingenuity pathway analysis was conducted for sciRNA targets in the mouse and human data sets (IPA ® , QIAGEN Redwood City, www.qiagen.com/ingenuity) using the default parameters. Gene Ontology (GO) analysis was carried out with our previous approach (11) for non-coding genes according to the functional annotations provided by NONCODEv4 (12) .
SNP enrichment. The union of all sciRNA binding sites located within B1 regions (i.e. the Alu Repeatmasker family) in predicted target genes of mESC, testis, and cerebellum were used (n = 1,510). Each position in the targeted region and 100 nt flanking region were interrogated for SNPs (dbSNP 138 (13)). To calculate a SNP density per nucleotide, the sum of SNPs at each position was normalized by the total sequences interrogated at that position. These values were smoothed using a sliding window of size 10nt and step size 1nt (Figure 5b ). The smoothed values were anchored on the rightmost nucleotide (e.g. the smoothed SNP density at position -100 is the average SNP density of the window -100 to -90). A chi-square p-value was calculated using a contingency table of total SNPs vs. the sum of length of B1 annotation (up to 100 nt) within vs. outside the target region.
Ago2 binding in canonical miRNA targets. Predicted canonical miRNA target sites were downloaded from microrna.org (14) . Targets of expressed miRNAs in mESCs (miRNA read count ≥ 20) located within B1 (Alu family) regions were separated into two groups based on whether or not they overlapped a sciRNA target sequence. A total of 102 unique miRNA targets overlapped a sciRNA target, and 54,766 did not. Among the latter, 53,333 (97%) did not contain a Deg-Seq peak, as expected. We refer to these 53,333 targets as "putative canonical miRNA B1 targets" and the 102 unique miRNA targets overlapping a sciRNA target as "putative sciRNA targets". To compare Ago2 CLIP-Seq overlap between the two groups, one "putative canonical miRNA B1 target" was randomly chosen for each "putative sciRNA target" (i.e. 102 vs. 102), and this process was repeated 1,000 times. Ago2 CLIP-Seq overlap was calculated as the sum of reads in the target site, divided by the length of target sequence. For each of the 1,001 total target and control sets, targets with zero Ago2 CLIP-Seq overlap were excluded and the average CLIPSeq overlap of the remaining targets was calculated. An empirical p-value was calculated by counting the total sets of random "putative canonical miRNA B1 targets" with higher average Ago2 CLIP-Seq density than the "putative sciRNA targets."
In Vitro Transcription
sciRNA targets were amplified using OneTaq DNA polymerase (NEB) from mouse genomic DNA followed by TOPO TA cloning (Life Technologies). The target-specific primers are listed in Supplementary Table S3 . The TOPO cloning products were then transformed into DH5α competent cells and were later plated for overnight incubation at 37°C. PCR and Sanger sequencing were used to verify the constructs.
Target RNAs were in vitro transcribed using 1 µg of template DNA and the HiScribe™ T7 High Yield RNA Synthesis Kit (NEB). To remove template DNA, 20U RNase-free DNase I (Roche Diagnostics) was applied for 15 min at 37°C followed by phenol extraction. In vitro transcribed RNA was purified from 10% PAGE gel. RNA was dephosphorylated by 10U calf intestinal alkaline phosphatase (NEB) at 37°C for 60 min and then purified by phenol-chloroform extraction. Two µg dephosphorylated RNA was labeled with γ-32 P ATP 150Ci (MPbio) by T4 Polynucleotide Kinase (NEB) at 37°C for 60 min followed by 12% PAGE gel isolation.
In Vitro Cleavage Assays
In vitro cleavage assays were performed as described previously (15) . HeLa cytoplasmic S100 extract was obtained from Speed BioSystems. For endogenous sciRNA cleavage (miR-708-5p and miR-29c-3p), HeLa cytoplasmic S100 extract (0, 0.1, 0.5, and 2 µg respectively) was incubated with 200 ng of 32 P-labeled target RNA at 37°C for 30 min in the cleavage buffer (20mM HEPES KOH pH7.9, 100mM KCl, 1.5mM MgCl 2 , 0.5mM DTT, 0.5mM PMSF, 1mM ATP, 0.2mM GTP). The cleavage reaction was terminated by adding 2X RNA gel loading buffer and incubated at 60°C for 5 min. Cleaved RNA was loaded onto 10-12% PAGE gel and exposed to X-ray film at -80°C.
For cleavage of Traf3ip2-as and Zfp389 target genes, endogenous sciRNA levels were relatively low. Thus, sciRNA +/-strands were annealed to form sciRNA duplexes as follows: [1] prepare the +/-strand sciRNAs (Supplementary Table S3 ) at a final concentration of 100 µM; [2] mix 2 µL of the two sciRNA strands with 5µL 10X Annealing Buffer (100 mM Tris-HCl, pH 7.5, 1 M NaCl, 10 mM EDTA); [3] add nuclease-free H 2 O to reach a total volume of 50 µL; [4] heat at 94°C in water bath for 4 min, 70°C for 10 min, and then allow cooling to room temperature; [5] annealed sciRNA duplex was further purified by 10% PAGE gel and precipitated with 2.5 volumes of absolute ethanol. HeLa cytoplasmic S100 extract was then preincubated with 50 nM purified sciRNA duplex at 37°C for 30 min before adding the 32 P-labeled target RNA. The cleavage reaction was otherwise carried out in the same way as described above. 
